Standard
Reply to : Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19. / Asselta, Rosanna; Paraboschi, Elvezia Maria; Stravalaci, Matteo; Invernizzi, Pietro; Bonfanti, Paolo; Biondi, Andrea; Pagani, Isabel; Pedotti, Mattia; Doni, Andrea; Scavello, Francesco; Mapelli, Sarah N.; Sironi, Marina; Perucchini, Chiara; Varani, Luca; Matkovic, Milos; Cavalli, Andrea; Cesana, Daniela; Gallina, Pierangela; Pedemonte, Nicoletta; Capurro, Valeria; Clementi, Nicola; Mancini, Nicasio; Bayarri-Olmos, Rafael; Garred, Peter; Rappuoli, Rino; Duga, Stefano; Bottazzi, Barbara; Uguccioni, Mariagrazia; Vicenzi, Elisa; Mantovani, Alberto; Garlanda, Cecilia.
In:
Nature Immunology, Vol. 23, No. 6, 2022, p. 865-867.
Research output: Contribution to journal › Letter › Research › peer-review
Harvard
Asselta, R, Paraboschi, EM, Stravalaci, M, Invernizzi, P, Bonfanti, P, Biondi, A, Pagani, I, Pedotti, M, Doni, A, Scavello, F, Mapelli, SN, Sironi, M, Perucchini, C, Varani, L, Matkovic, M, Cavalli, A, Cesana, D, Gallina, P, Pedemonte, N, Capurro, V, Clementi, N, Mancini, N, Bayarri-Olmos, R
, Garred, P, Rappuoli, R, Duga, S, Bottazzi, B, Uguccioni, M, Vicenzi, E, Mantovani, A & Garlanda, C 2022, '
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19',
Nature Immunology, vol. 23, no. 6, pp. 865-867.
https://doi.org/10.1038/s41590-022-01228-9APA
Asselta, R., Paraboschi, E. M., Stravalaci, M., Invernizzi, P., Bonfanti, P., Biondi, A., Pagani, I., Pedotti, M., Doni, A., Scavello, F., Mapelli, S. N., Sironi, M., Perucchini, C., Varani, L., Matkovic, M., Cavalli, A., Cesana, D., Gallina, P., Pedemonte, N., ... Garlanda, C. (2022).
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19.
Nature Immunology,
23(6), 865-867.
https://doi.org/10.1038/s41590-022-01228-9Vancouver
Asselta R, Paraboschi EM, Stravalaci M, Invernizzi P, Bonfanti P, Biondi A et al.
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19.
Nature Immunology. 2022;23(6):865-867.
https://doi.org/10.1038/s41590-022-01228-9Author
Asselta, Rosanna ; Paraboschi, Elvezia Maria ; Stravalaci, Matteo ; Invernizzi, Pietro ; Bonfanti, Paolo ; Biondi, Andrea ; Pagani, Isabel ; Pedotti, Mattia ; Doni, Andrea ; Scavello, Francesco ; Mapelli, Sarah N. ; Sironi, Marina ; Perucchini, Chiara ; Varani, Luca ; Matkovic, Milos ; Cavalli, Andrea ; Cesana, Daniela ; Gallina, Pierangela ; Pedemonte, Nicoletta ; Capurro, Valeria ; Clementi, Nicola ; Mancini, Nicasio ; Bayarri-Olmos, Rafael ; Garred, Peter ; Rappuoli, Rino ; Duga, Stefano ; Bottazzi, Barbara ; Uguccioni, Mariagrazia ; Vicenzi, Elisa ; Mantovani, Alberto ; Garlanda, Cecilia. / Reply to : Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19. In: Nature Immunology. 2022 ; Vol. 23, No. 6. pp. 865-867.
Bibtex
@article{3b6ec0e2abb447619dc2df52a46561df,
title = "Reply to: Hultstr{\"o}m et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19",
author = "Rosanna Asselta and Paraboschi, {Elvezia Maria} and Matteo Stravalaci and Pietro Invernizzi and Paolo Bonfanti and Andrea Biondi and Isabel Pagani and Mattia Pedotti and Andrea Doni and Francesco Scavello and Mapelli, {Sarah N.} and Marina Sironi and Chiara Perucchini and Luca Varani and Milos Matkovic and Andrea Cavalli and Daniela Cesana and Pierangela Gallina and Nicoletta Pedemonte and Valeria Capurro and Nicola Clementi and Nicasio Mancini and Rafael Bayarri-Olmos and Peter Garred and Rino Rappuoli and Stefano Duga and Barbara Bottazzi and Mariagrazia Uguccioni and Elisa Vicenzi and Alberto Mantovani and Cecilia Garlanda",
note = "Funding Information: This work was conducted in the framework of, and made possible by, the collective effort of the Humanitas COVID-19 Task Force, the Humanitas Gavazzeni COVID-19 Task Force and the COVID-19 Storm trial. This paper is dedicated to S. Duga, who passed on 10 November 2021 and had made a key contribution to the genetic section of this report. This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to A.M. and C.G.), by the Italian Ministry of Health for COVID-19 (grant no. COVID-2020-12371640 to A.M. and C.G.), by the Italian Ministry of University and Research (to P.I.), by the Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to the clinic, to P.I.) and by Fondazione Cariplo (Biobanking of COVID-19 patient samples to support national and international research, to A.B.). We also thank the Banca Intesa San Paolo for their generous contribution (to R.A.) and AMAF Monza ONLUS and AIRCS for unrestricted research funding. L.V. received funding from the European Union{\textquoteright}s Horizon 2020 research and innovation program under grant agreement no. 101003650 and from the Swiss National Science Foundation (grant no. 31003A_182270). Funding Information: This work was conducted in the framework of, and made possible by, the collective effort of the Humanitas COVID-19 Task Force, the Humanitas Gavazzeni COVID-19 Task Force and the COVID-19 Storm trial. This paper is dedicated to S. Duga, who passed on 10 November 2021 and had made a key contribution to the genetic section of this report. This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to A.M. and C.G.), by the Italian Ministry of Health for COVID-19 (grant no. COVID-2020-12371640 to A.M. and C.G.), by the Italian Ministry of University and Research (to P.I.), by the Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to the clinic, to P.I.) and by Fondazione Cariplo (Biobanking of COVID-19 patient samples to support national and international research, to A.B.). We also thank the Banca Intesa San Paolo for their generous contribution (to R.A.) and AMAF Monza ONLUS and AIRCS for unrestricted research funding. L.V. received funding from the European Union{\textquoteright}s Horizon 2020 research and innovation program under grant agreement no. 101003650 and from the Swiss National Science Foundation (grant no. 31003A_182270). ",
year = "2022",
doi = "10.1038/s41590-022-01228-9",
language = "English",
volume = "23",
pages = "865--867",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "nature publishing group",
number = "6",
}
RIS
TY - JOUR
T1 - Reply to
T2 - Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19
AU - Asselta, Rosanna
AU - Paraboschi, Elvezia Maria
AU - Stravalaci, Matteo
AU - Invernizzi, Pietro
AU - Bonfanti, Paolo
AU - Biondi, Andrea
AU - Pagani, Isabel
AU - Pedotti, Mattia
AU - Doni, Andrea
AU - Scavello, Francesco
AU - Mapelli, Sarah N.
AU - Sironi, Marina
AU - Perucchini, Chiara
AU - Varani, Luca
AU - Matkovic, Milos
AU - Cavalli, Andrea
AU - Cesana, Daniela
AU - Gallina, Pierangela
AU - Pedemonte, Nicoletta
AU - Capurro, Valeria
AU - Clementi, Nicola
AU - Mancini, Nicasio
AU - Bayarri-Olmos, Rafael
AU - Garred, Peter
AU - Rappuoli, Rino
AU - Duga, Stefano
AU - Bottazzi, Barbara
AU - Uguccioni, Mariagrazia
AU - Vicenzi, Elisa
AU - Mantovani, Alberto
AU - Garlanda, Cecilia
N1 - Funding Information:
This work was conducted in the framework of, and made possible by, the collective effort of the Humanitas COVID-19 Task Force, the Humanitas Gavazzeni COVID-19 Task Force and the COVID-19 Storm trial. This paper is dedicated to S. Duga, who passed on 10 November 2021 and had made a key contribution to the genetic section of this report. This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to A.M. and C.G.), by the Italian Ministry of Health for COVID-19 (grant no. COVID-2020-12371640 to A.M. and C.G.), by the Italian Ministry of University and Research (to P.I.), by the Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to the clinic, to P.I.) and by Fondazione Cariplo (Biobanking of COVID-19 patient samples to support national and international research, to A.B.). We also thank the Banca Intesa San Paolo for their generous contribution (to R.A.) and AMAF Monza ONLUS and AIRCS for unrestricted research funding. L.V. received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 101003650 and from the Swiss National Science Foundation (grant no. 31003A_182270).
Funding Information:
This work was conducted in the framework of, and made possible by, the collective effort of the Humanitas COVID-19 Task Force, the Humanitas Gavazzeni COVID-19 Task Force and the COVID-19 Storm trial. This paper is dedicated to S. Duga, who passed on 10 November 2021 and had made a key contribution to the genetic section of this report. This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to A.M. and C.G.), by the Italian Ministry of Health for COVID-19 (grant no. COVID-2020-12371640 to A.M. and C.G.), by the Italian Ministry of University and Research (to P.I.), by the Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to the clinic, to P.I.) and by Fondazione Cariplo (Biobanking of COVID-19 patient samples to support national and international research, to A.B.). We also thank the Banca Intesa San Paolo for their generous contribution (to R.A.) and AMAF Monza ONLUS and AIRCS for unrestricted research funding. L.V. received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 101003650 and from the Swiss National Science Foundation (grant no. 31003A_182270).
PY - 2022
Y1 - 2022
U2 - 10.1038/s41590-022-01228-9
DO - 10.1038/s41590-022-01228-9
M3 - Letter
C2 - 35624207
AN - SCOPUS:85131007388
VL - 23
SP - 865
EP - 867
JO - Nature Immunology
JF - Nature Immunology
SN - 1529-2908
IS - 6
ER -
